The findings were verified to be reliable by publication bias and sensitivity analyses.<h4>Conclusion</h4>High CRP remarkably predicts dismal OS and PFS of melanoma cases, which is the promising biomarker used to forecast melanoma prognosis in clinical practice. Here, CRP is linked to melanoma.